SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-091471
Filing Date
2017-03-22
Accepted
2017-03-22 08:00:57
Documents
5
Period of Report
2017-05-02
Effectiveness Date
2017-03-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d350042ddef14a.htm DEF 14A 432628
2 GRAPHIC g350042g50m27.jpg GRAPHIC 5644
3 GRAPHIC g350042g63b11.jpg GRAPHIC 23049
4 GRAPHIC g350042x.jpg GRAPHIC 4000
5 GRAPHIC g350042xx.jpg GRAPHIC 3997
  Complete submission text file 0001193125-17-091471.txt   484522
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36076 | Film No.: 17705703
SIC: 2836 Biological Products, (No Diagnostic Substances)